BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lorente L. Biomarkers Associated with the Outcome of Traumatic Brain Injury Patients. Brain Sci 2017;7:E142. [PMID: 29076989 DOI: 10.3390/brainsci7110142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mirshekar MA, Shahraki M, Najafi R, Shabani S. The ameliorative effects of myricetin on neurobehavioral activity, electrophysiology, and biochemical changes in an animal model of traumatic brain injury. Learning and Motivation 2019;68:101597. [DOI: 10.1016/j.lmot.2019.101597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Bryden DW, Tilghman JI, Hinds SR 2nd. Blast-Related Traumatic Brain Injury: Current Concepts and Research Considerations. J Exp Neurosci 2019;13:1179069519872213. [PMID: 31548796 DOI: 10.1177/1179069519872213] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
3 Yin W, Weng S, Lai S, Nie H. [GCS score combined with CT score and serum S100B protein level Can evaluate severity and early prognosis of acute traumatic brain injury]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:543-8. [PMID: 33963713 DOI: 10.12122/j.issn.1673-4254.2021.04.09] [Reference Citation Analysis]
4 Gudowska-Sawczuk M, Mroczko B. Selected Biomarkers of Tick-Borne Encephalitis: A Review. Int J Mol Sci 2021;22:10615. [PMID: 34638953 DOI: 10.3390/ijms221910615] [Reference Citation Analysis]
5 Lorente L, Martín MM, Pérez-cejas A, González-rivero AF, Argueso M, Ramos L, Solé-violán J, Cáceres JJ, Jiménez A, García-marín V. Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury. World Neurosurgery 2019;132:e613-7. [DOI: 10.1016/j.wneu.2019.08.064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Agoston DV, Kamnaksh A. Protein biomarkers of epileptogenicity after traumatic brain injury. Neurobiol Dis 2019;123:59-68. [PMID: 30030023 DOI: 10.1016/j.nbd.2018.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
7 Rahat B, Ali T, Sapehia D, Mahajan A, Kaur J. Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine. Front Genet 2020;11:844. [PMID: 32849827 DOI: 10.3389/fgene.2020.00844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 He H, Li X, He Y. Hyperbaric oxygen therapy attenuates neuronal apoptosis induced by traumatic brain injury via Akt/GSK3β/β-catenin pathway. Neuropsychiatr Dis Treat 2019;15:369-74. [PMID: 30774348 DOI: 10.2147/NDT.S183632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Rana A, Singh S, Sharma R, Kumar A. Traumatic Brain Injury Altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics Approaches. Curr Neuropharmacol 2019;17:614-29. [PMID: 30207236 DOI: 10.2174/1570159X16666180911121847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ladak AA, Enam SA, Ibrahim MT. A Review of the Molecular Mechanisms of Traumatic Brain Injury. World Neurosurg 2019;131:126-32. [PMID: 31301445 DOI: 10.1016/j.wneu.2019.07.039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
11 Kwon BK, Bloom O, Wanner IB, Curt A, Schwab JM, Fawcett J, Wang KK. Neurochemical biomarkers in spinal cord injury. Spinal Cord 2019;57:819-31. [PMID: 31273298 DOI: 10.1038/s41393-019-0319-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
12 Regner A, Meirelles LDS, Ikuta N, Cecchini A, Simon D. Prognostic utility of circulating nucleic acids in acute brain injuries. Expert Rev Mol Diagn 2018;18:925-38. [PMID: 30307786 DOI: 10.1080/14737159.2018.1535904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Sieber M, Dreßler J, Franke H, Pohlers D, Ondruschka B. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury? J Forensic Leg Med 2018;55:65-73. [PMID: 29471249 DOI: 10.1016/j.jflm.2018.02.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
14 Dietrich WD, Bramlett HM. Therapeutic hypothermia and targeted temperature management for traumatic brain injury: Experimental and clinical experience. Brain Circ 2017;3:186-98. [PMID: 30276324 DOI: 10.4103/bc.bc_28_17] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
15 Smith ES, Porterfield JE, Kannan RM. Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders. Adv Drug Deliv Rev 2019;148:181-203. [PMID: 30844410 DOI: 10.1016/j.addr.2019.02.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Suehiro E, Fujiyama Y, Kiyohira M, Motoki Y, Nojima J, Suzuki M. Probability of Soluble Tissue Factor Release Lead to the Elevation of D-dimer as a Biomarker for Traumatic Brain Injury. Neurol Med Chir (Tokyo) 2019;59:63-7. [PMID: 30674749 DOI: 10.2176/nmc.oa.2018-0254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Michetti F, Di Sante G, Clementi ME, Sampaolese B, Casalbore P, Volonté C, Romano Spica V, Parnigotto PP, Di Liddo R, Amadio S, Ria F. Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders. Neurosci Biobehav Rev 2021;127:446-58. [PMID: 33971224 DOI: 10.1016/j.neubiorev.2021.04.035] [Reference Citation Analysis]
18 Lorente L, Rodriguez ST, Sanz P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation. Expert Rev Mol Diagn 2019;19:635-40. [PMID: 31084510 DOI: 10.1080/14737159.2019.1619549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Arnerić SP, Kern VD, Stephenson DT. Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments. Biochem Pharmacol 2018;151:291-306. [PMID: 29410157 DOI: 10.1016/j.bcp.2018.01.043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]